Cytokinetics | CYTK - Loan Capital


Cytokinetics reported $248.2M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Amgen USD 51.86B 27M Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
Biogen USD 7.29B 1B Jun/2026
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 248.2M 993K Jun/2026
Eisai JPY 184.6B 49.83B Jun/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
Geron USD 120.13M 298K Jun/2026
Halozyme Therapeutics USD 1.94B 1.79M Jun/2026
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
Ligand Pharmaceuticals USD 446.9M 704K Mar/2026
Merck USD 51.08B 4.41B Jun/2026
Novartis USD 37.49B 42M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026